-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Entero Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2023.
- Entero Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was $5.57M.
- Entero Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$6.16M, a 32.1% increase year-over-year.
- Entero Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$15.8M, a 7.97% decline from 2022.
- Entero Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.6M, a 75% increase from 2021.
- Entero Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$58.5M, a 79.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)